Watch a 39-minute webinar exploring advanced genetic discovery systems in human immune cells, presented by Dr. Theo Roth, a distinguished MD/PhD from Stanford University and UCSF. Learn about the development of non-viral genome targeting and pooled knock-in screening techniques that enable efficient genetic engineering of primary human immune cells. Discover how these innovative methods are revolutionizing cancer immunotherapy through the creation of engineered immune cell therapies. Explore the Modular Pooled Knockin Screening (ModPoKI) platform, which allows for rapid assessment of T cell genetic modifications across various cancer immunotherapy contexts. Healthcare professionals can earn PACE credits through Labroots upon completion of the webinar, valid until October 2026.